Pharmacovigilance Market Is Anticipated to Grow US$ 6,104.1 Mn by 2020
Growth of the pharmacovigilance market is mainly driven by rising prevalence of acute and chronic diseases, continuously increasing drug event monitoring as a result of the increasing drug consumption, surge in adverse drug reactions and drug toxicity and rise in adoption of outsourcing services.
View full press release